NCT07620379

Brief Summary

The hypothesis of this study is based on the premise that pressure-distributing materials with superior biomechanical and tissue response properties will be capable of improving the healing rate of neuropathic ulcers. The overarching objective of the present project is to assess the influence of the nature and method of application of the materials under study on tissue response, the reduction of pressure on the sole of the foot, and the healing of neuropathic ulcers in patients with diabetes mellitus.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Mar 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Mar 2021Mar 2027

Study Start

First participant enrolled

March 9, 2021

Completed
5.2 years until next milestone

First Submitted

Initial submission to the registry

May 13, 2026

Completed
20 days until next milestone

First Posted

Study publicly available on registry

June 2, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 8, 2027

Last Updated

June 2, 2026

Status Verified

May 1, 2026

Enrollment Period

5.8 years

First QC Date

May 13, 2026

Last Update Submit

May 26, 2026

Conditions

Keywords

diabetic footplantar pressureoffloadingfelt paddinghyperspectral imagingthermographypressure redistributionulcer prevention

Outcome Measures

Primary Outcomes (1)

  • Near-infrared perfusion index (NIR perfusion)

    Hyperspectral imaging was performed using the TIVITA® 2.0 camera (Diaspective Vision GmbH, Germany). This non-contact, non-invasive device captures images across multiple wavelengths within the visible and near-infrared spectrum (500-1000 nm), enabling assessment of microcirculatory parameters up to a tissue depth of approximately 8 mm. The device provides an image resolution of 640 × 480 pixels, with an acquisition time of 6.4 seconds. Images were analyzed using TIVITA® Suite software by selecting a circular region of interest adjusted to the metatarsal head and offloading area under study.

    Baseline and 4 days

Secondary Outcomes (7)

  • Thermography

    Baseline and 4 days

  • Peak pressure (Pmax)

    Baseline and 4 days

  • Tissue oxygen saturation (StO₂)

    Baseline and 4 days

  • Tissue hemoglobin index (THI)

    Baseline and 4 days

  • Tissue wáter index (TWI)

    Baseline and 4 days

  • +2 more secondary outcomes

Study Arms (1)

felt padding

EXPERIMENTAL

The 5 mm and 10 mm felt pads are applied for 4 days.

Other: felt padding

Interventions

The 5 mm felt pad is applied for 4 days and then removed. After allowing the skin at least 48 hours to recover, the 10 mm felt pad is applied, also for 4 days.

felt padding

Eligibility Criteria

Age55 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged between 55 and 75.
  • Diagnosis of diabetes mellitus.
  • Patients with an ankle-brachial index of \>0.8 and \<1.2.
  • Signature of the informed consent form

You may not qualify if:

  • Leg or foot injuries or ulcers that cause pain and prevent normal movement in both lower limbs.
  • Foot trauma within the last month.
  • Inability to adhere to the full schedule of measurements required by the study.
  • Participants who do not sign the informed consent form.
  • Known contact dermatitis to any of the study materials

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario y Politécnico La Fe

Valencia, Valencia, Spain

RECRUITING

MeSH Terms

Conditions

Diabetes ComplicationsDiabetic Foot

Condition Hierarchy (Ancestors)

Diabetes MellitusEndocrine System DiseasesDiabetic AngiopathiesVascular DiseasesCardiovascular DiseasesFoot UlcerLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue DiseasesDiabetic Neuropathies

Central Study Contacts

IVAN JULIAN ROCHINA, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Medicine

Study Record Dates

First Submitted

May 13, 2026

First Posted

June 2, 2026

Study Start

March 9, 2021

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

March 8, 2027

Last Updated

June 2, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations